Please login to the form below
New Accounts, June, 2009, Advertising
New pharmaceutical account wins notified to us by the winning agency for the period April 2009 and June 2009 inclusive:
New pharmaceutical account wins notified to us by the winning agency for the period April 2009 and June 2009 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| Abbott Laboratories/ International | Kaletra | Virology | Grace Agency |
| ApaTech | Actifuse | Bone graft material | Fleishman-Hillard International |
| Bausch & Lomb | Ocuvite | Ophthalmology (OTC) | Pulsar Healthcare Communications |
| Bausch & Lomb | PreserVision | Ophthalmology (OTC) | Pulsar Healthcare Communications |
| Baxter Healthcare Renal Division | Home dialysis | Renal | Life |
| Boehringer Ingelheim | New product launch | Women's Health | MSA Market Media |
| Bupa Home Healthcare | N/A | Corporate | Pulsar Healthcare Communications |
| CarieScan | CarieScan | Dentistry | Pulsar Healthcare Communications |
| Gilead | Early treatment project | HIV | Life |
| IS Pharma | Haemopressin/ Variquel (Europe) | Hepatology | Pulsar Healthcare Communications |
| Novo Nordisk | NovoSeven corporate | Haemophilia | Life |
| Reckitt Benckiser | Nurofen | Analgesia | Hive |
| Spectrum Thea | Virgan | Ophthalmology | Pulsar Healthcare Communications |
| Teva Ireland | Naramerg | CNS | Pulsar Healthcare Communications |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
